Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Bio-Techne Corp (NQ: TECH ) 72.29 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Bio-Techne Corp < Previous 1 2 3 4 Next > NexImmune Price Target Cut By 75%, Plus Wells Fargo Lowers PT Price Target On These Stocks August 16, 2022 Raymond James cut the price target for NexImmune, Inc. (NASDAQ: NEXI) from $12 to $3. NexImmune shares rose 2.4% to $1.29 in pre-market trading. Via Benzinga Recap: Bio-Techne Q4 Earnings August 04, 2022 Bio-Techne (NASDAQ:TECH) reported its Q4 earnings results on Thursday, August 4, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Via Benzinga Tackling Recurring Health Conditions Offers Hope to Patients June 21, 2022 Palm Beach, FL – June 21, 2022 – FinancialNewsMedia.com News Commentary – Being diagnosed with a health condition can often come as a shock but finding out it can recur is a double blow, particularly... Via FinancialNewsMedia 7 Defensive Growth Stocks to Buy for a Shaky Market May 21, 2022 These are the best defensive growth stocks to invest in now. Each of these can make great investments if/when the market sours. Via InvestorPlace Recap: Bio-Techne Q3 Earnings May 04, 2022 Bio-Techne (NASDAQ:TECH) reported its Q3 earnings results on Wednesday, May 4, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Via Benzinga Bio-Techne Clocks 17% Organic Revenue Growth In Q2, Announces $400M Share Buyback February 01, 2022 Bio-Techne Corporation (NASDAQ: TECH) has posted Q2 FY22 s Via Benzinga Earnings Scheduled For November 2, 2021 November 02, 2021 Companies Reporting Before The Bell • Thomson Reuters (NYSE:TRI) is expected to report quarterly earnings at $0.48 per share on revenue of $1.86 billion. •... Via Benzinga Stocks That Hit 52-Week Lows On Tuesday June 14, 2022 On Tuesday, 951 companies hit new 52-week lows. Via Benzinga Understanding Bio-Techne's Unusual Options Activity August 04, 2021 Shares of Bio-Techne (NASDAQ:TECH) saw some unusual option... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2022 April 25, 2022 Via Benzinga 7 Superior Stocks That Smart Investors Will Buy on the Dip February 07, 2022 The recent sell-off presents long-term investors with many robust stocks to buy on the dip. These seven provide a start. Via InvestorPlace 10 Biggest Price Target Changes For Wednesday February 02, 2022 Keybanc lifted the price target for Alphabet Inc. (NASDAQ: GOOGL) from $3,090 to $3,400. Alphabet shares surged 11% to $3,055.00 in pre-market trading. Via Benzinga The Daily Biotech Pulse: ImmunityBio Reports Positive Readout, Valneva Starts Late-Stage Chikungunya Vaccine Study, Sio Gene Shelves Parkinson's Program February 01, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Here's How Much You Would Have Made Owning Bio-Techne Stock In The Last 5 Years December 03, 2021 Bio-Techne (NASDAQ:TECH) has outperformed the market over the past 5 years by 17.84% on an annualized basis. Buying $1,000.00 In TECH: 5 years ago, an investor could have... Via Benzinga Bio-Techne Corporation (TECH) Q1 2022 Earnings Call Transcript November 02, 2021 TECH earnings call for the period ending September 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US November 02, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus SAB Spikes On Analyst Action SAB Biotherapeutics, Inc. (NASDAQ: SABS) shares... Via Benzinga Exposures COVID-19 Bio-Techne's Earnings: A Preview November 01, 2021 Bio-Techne (NASDAQ:TECH) is set to give its latest quarterly earnings report on Tuesday, 2021-11-02. Here's what investors need to know before the announcement. Analysts estimate... Via Benzinga The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study September 16, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15) Alcon Inc. (NYSE: ALC)... Via Benzinga A Peek Into The Markets: US Stock Futures Rise Ahead Of Economic Data; Crude Oil Gains 1% September 15, 2021 Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Dow Jones dipped nearly 300 points in the previous week. Investors are awaiting earnings... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline October 31, 2021 Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... Via Benzinga The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout September 14, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13) Abbott Laboratories (NYSE... Via Benzinga Exposures COVID-19 Director Of Bio-Techne Trades $4.80 Million In Company Stock September 09, 2021 Randolph C Steer, Director at Bio-Techne (NASDAQ:TECH), made a large buy and sell of company shares on September 7, according to a new SEC filing. What Happened: A Form 4 filing... Via Benzinga Topics Regulatory Compliance Exposures Legal Regulatory CFO Of Bio-Techne Trades $6.14 Million In Company Stock September 08, 2021 James Hippel, Chief Financial Officer at Bio-Techne (NASDAQ:TECH), made a large buy and sell of company shares on September 2, according to a new SEC filing. What Happened: A Form... Via Benzinga Topics Regulatory Compliance Exposures Legal Regulatory The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself September 03, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:... Via Benzinga Bio-Techne Corporation (TECH) Q4 2021 Earnings Call Transcript August 05, 2021 TECH earnings call for the period ending June 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial Stocks That Hit 52-Week Highs On Thursday August 05, 2021 On Thursday morning, 159 companies achieved new highs for the year. Things to Consider: The largest company by market cap to break to a new 52-week high was ASML... Via Benzinga The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical August 31, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)... Via Benzinga Recap: Bio-Techne Q4 Earnings August 05, 2021 Shares of Bio-Techne (NASDAQ:TECH) were unchanged after the company reported Q4 results. Quarterly Results Earnings per share were up 87.00% over the past year to $1.87,... Via Benzinga The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO August 06, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)... Via Benzinga Earnings Scheduled For August 5, 2021 August 05, 2021 Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million. •... Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.